Korean J Gastroenterol.  2020 Dec;76(6):275-281. 10.4166/kjg.2020.160.

Inflammatory Bowel Disease and Vitamin D

• Kim KB
• Kim HW
• Lee JS
• Yoon SM

• KMID: 2509704
• DOI: http://doi.org/10.4166/kjg.2020.160

Abstract

Vitamin D contributes to bone metabolism and acts as an immune modulator for both innate and adaptive immunity. The serum level of vitamin D has been associated with inflammatory diseases, such as inflammatory bowel disease (IBD). In epidemiologic studies, IBD patients have been shown to have low levels of vitamin D. The suboptimal circulating levels of vitamin D in IBD patients may be caused by low exposure to sunlight, dietary malabsorption, and the impaired conversion of active metabolites (1,25[OH] 2D). Recent studies have demonstrated that vitamin D deficiency in IBD can increase the chance of disease recurrence, IBD-related hospitalization or surgery, and deterioration of quality of life. Supplementation with vitamin D is therefore thought to reduce the risk of flare-ups and the improvement of the quality of life in IBD patients. This review aims to summarize the latest knowledge on the effects of vitamin D deficiency on IBD and the possible benefits of vitamin D supplementation in IBD patients.

Keyword

Inflammatory bowel diseases; Vitamin D; Deficiency; Supplement

Reference

1. Molodecky NA, Soon IS, Rabi DM, et al. 2012; Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 142:46–54. e42. quiz e30. DOI: 10.1053/j.gastro.2011.10.001. PMID: 22001864.

2. Ng SC, Shi HY, Hamidi N, et al. 2018; Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 390:2769–2778. DOI: 10.1016/S0140-6736(17)32448-0.

3. de Souza HS, Fiocchi C. 2016; Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 13:13–27. DOI: 10.1038/nrgastro.2015.186. PMID: 26627550.

4. Choi HS, Oh HJ, Choi H, et al. 2011; Vitamin D insufficiency in Korea--a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab. 96:643–651. DOI: 10.1210/jc.2010-2133. PMID: 21190984.

5. Dolatshahi S, Pishgar E, Jamali R. 2016; Does serum 25 hydroxy vitamin D level predict disease activity in ulcerative colitis patients? Acta Clin Belg. 71:46–50. DOI: 10.1080/17843286.2015.1110895. PMID: 27075790.

6. Frigstad SO, Høivik M, Jahnsen J, et al. 2017; Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 52:100–106. DOI: 10.1080/00365521.2016.1233577. PMID: 27603182.

7. Ko KH, Kim YS, Lee BK, et al. 2019; Vitamin D deficiency is associated with disease activity in patients with Crohn's disease. Intest Res. 17:70–77. DOI: 10.5217/ir.2018.00022. PMID: 30301338. PMCID: PMC6361011.

8. Sauer CG, Loop MS, Venkateswaran S, et al. 2018; Free and bio-available 25-hydroxyvitamin D concentrations are associated with disease activity in pediatric patients with newly diagnosed treatment naïve ulcerative colitis. Inflamm Bowel Dis. 24:641–650. DOI: 10.1093/ibd/izx052. PMID: 29462384. PMCID: PMC6176888.

9. Schäffler H, Schmidt M, Huth A, Reiner J, Glass Ä, Lamprecht G. 2018; Clinical factors are associated with vitamin D levels in IBD patients: a retrospective analysis. J Dig Dis. 19:24–32. DOI: 10.1111/1751-2980.12565. PMID: 29232067.

10. Ulitsky A, Ananthakrishnan AN, Naik A, et al. 2011; Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 35:308–316. DOI: 10.1177/0148607110381267. PMID: 21527593.

11. Han YM, Yoon H, Lim S, et al. 2017; Risk factors for vitamin D, zinc, and selenium deficiencies in Korean patients with inflammatory bowel disease. Gut Liver. 11:363–369. DOI: 10.5009/gnl16333. PMID: 28208007. PMCID: PMC5417778.

12. Ham NS, Hwang SW, Oh EH, et al. 2020; Mar. 26. Influence of severe vitamin D deficiency on the clinical course of inflammatory bowel disease. Dig Dis Sci. [Epub ahead of print]. DOI: 10.1007/s10620-020-06207-4.

13. Rhodes LE, Webb AR, Fraser HI, et al. 2010; Recommended summer sunlight exposure levels can produce sufficient (> or =20 ng ml(-1)) but not the proposed optimal (> or =32 ng ml(-1)) 25(OH)D levels at UK latitudes. J Invest Dermatol. 130:1411–1418. DOI: 10.1038/jid.2009.417. PMID: 20072137.

14. Bours PH, Wielders JP, Vermeijden JR, van de Wiel A. 2011; Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease. Osteoporos Int. 22:2857–2867. DOI: 10.1007/s00198-010-1484-y. PMID: 21113577. PMCID: PMC3186887.

15. Lee A, Kim SH, Nam CM, Kim YJ, Joo SH, Lee KR. 2016; Prevalence of vitamin D deficiency and insufficiency in Korean children and adolescents and associated factors. Lab Med Online. 6:70–78. DOI: 10.3343/lmo.2016.6.2.70.

16. Ross AC, Manson JE, Abrams SA, et al. 2011; The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 96:53–58. DOI: 10.1210/jc.2010-2704. PMID: 21118827. PMCID: PMC3046611.

17. Raftery T, O'Sullivan M. 2015; Optimal vitamin D levels in Crohn's disease: a review. Proc Nutr Soc. 74:56–66. DOI: 10.1017/S0029665114001591. PMID: 25497215.

18. Reich KM, Fedorak RN, Madsen K, Kroeker KI. 2014; Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. World J Gastroenterol. 20:4934–4947. DOI: 10.3748/wjg.v20.i17.4934. PMID: 24803805. PMCID: PMC4009525.

19. Nielsen OH, Rejnmark L, Moss AC. 2018; Role of vitamin D in the natural history of inflammatory bowel disease. J Crohns Colitis. 12:742–752. DOI: 10.1093/ecco-jcc/jjy025. PMID: 29529167.

20. Adams JS, Hewison M. 2008; Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 4:80–90. DOI: 10.1038/ncpendmet0716. PMID: 18212810. PMCID: PMC2678245.

21. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. 2003; A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 17:2386–2392. DOI: 10.1210/me.2003-0281. PMID: 14500760.

22. Liu W, Chen Y, Golan MA, et al. 2013; Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest. 123:3983–3996. DOI: 10.1172/JCI65842. PMID: 23945234. PMCID: PMC3754241.

23. Cantorna MT. 2012; Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch Biochem Biophys. 523:103–106. DOI: 10.1016/j.abb.2011.11.001. PMID: 22085500. PMCID: PMC3374859.

24. gensen SP Jr, Hvas CL, Agnholt J, Christensen LA, Heickendorff L, Dahlerup JF. 2013; Active Crohn's disease is associated with low vitamin D levels. J Crohns Colitis. 7:e407–e413. DOI: 10.1016/j.crohns.2013.01.012. PMID: 23403039.

25. Bacchetta J, Zaritsky JJ, Sea JL, et al. 2014; Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol. 25:564–572. DOI: 10.1681/ASN.2013040355. PMID: 24204002. PMCID: PMC3935584.

26. Zhang YG, Wu S, Lu R, et al. 2015; Tight junction CLDN2 gene is a direct target of the vitamin D receptor. Sci Rep. 5:10642. DOI: 10.1038/srep10642. PMID: 26212084. PMCID: PMC4650691.

27. Naderpoor N, Mousa A, Fernanda Gomez Arango L, Barrett HL, Dekker Nitert M, de Courten B. 2019; Effect of vitamin D supplementation on faecal microbiota: a randomised clinical trial. Nutrients. 11:2888. DOI: 10.3390/nu11122888. PMID: 31783602. PMCID: PMC6950585.

28. McCarthy D, Duggan P, O'Brien M, et al. 2005; Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther. 21:1073–1083. DOI: 10.1111/j.1365-2036.2005.02446.x. PMID: 15854168.

29. Gilman J, Shanahan F, Cashman KD. 2006; Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr. 60:889–896. DOI: 10.1038/sj.ejcn.1602395. PMID: 16493452.

30. Pappa HM, Gordon CM, Saslowsky TM, et al. 2006; Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics. 118:1950–1961. DOI: 10.1542/peds.2006-0841. PMID: 17079566. PMCID: PMC3205440.

31. Suibhne TN, Cox G, Healy M, O'Morain C, O'Sullivan M. 2012; Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. J Crohns Colitis. 6:182–188. DOI: 10.1016/j.crohns.2011.08.002. PMID: 22325172.

32. Dumitrescu G, Mihai C, Dranga M, Prelipcean CC. 2014; Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. World J Gastroenterol. 20:2392–2396. DOI: 10.3748/wjg.v20.i9.2392. PMID: 24605037. PMCID: PMC3942843.

33. Govani SM, Higgins PD, Stidham RW, Montain SJ, Waljee AK. 2015; Increased ultraviolet light exposure is associated with reduced risk of inpatient surgery among patients with Crohn's disease. J Crohns Colitis. 9:77–81. DOI: 10.1093/ecco-jcc/jju002. PMID: 25518047.

34. Pallav K, Riche D, May WL, Sanchez P, Gupta NK. 2017; Predictors of vitamin D deficiency in inflammatory bowel disease and health: a Mississippi perspective. World J Gastroenterol. 23:638–645. DOI: 10.3748/wjg.v23.i4.638. PMID: 28216970. PMCID: PMC5292337.

35. Caviezel D, Maissen S, Niess JH, Kiss C, Hruz P. 2018; High prevalence of vitamin D deficiency among patients with inflammatory bowel disease. Inflamm Intest Dis. 2:200–210. DOI: 10.1159/000489010. PMID: 30221147. PMCID: PMC6135223.

36. Arihiro S, Nakashima A, Matsuoka M, et al. 2019; Randomized trial of vitamin D supplementation to prevent seasonal influenza and upper respiratory infection in patients with inflammatory bowel disease. Inflamm Bowel Dis. 25:1088–1095. DOI: 10.1093/ibd/izy346. PMID: 30601999. PMCID: PMC6499936.

37. Chatu S, Chhaya V, Holmes R, et al. 2013; Factors associated with vitamin D deficiency in a multicultural inflammatory bowel disease cohort. Frontline Gastroenterol. 4:51–56. DOI: 10.1136/flgastro-2012-100231. PMID: 28839700. PMCID: PMC5369785.

38. Lee S, Metcalfe A, Raman M, et al. 2018; Pregnant women with inflammatory bowel disease are at increased risk of vitamin D insufficiency: a cross-sectional study. J Crohns Colitis. 12:702–709. DOI: 10.1093/ecco-jcc/jjy030. PMID: 29546360. PMCID: PMC5972591.

39. Zullow S, Jambaulikar G, Rustgi A, Quezada S, Cross RK. 2017; Risk factors for vitamin D deficiency and impact of repletion in a tertiary care inflammatory bowel disease population. Dig Dis Sci. 62:2072–2078. DOI: 10.1007/s10620-017-4614-y. PMID: 28547646.

40. Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN. 2003; The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol. 17:473–478. DOI: 10.1155/2003/391308. PMID: 12945007.

41. Ananthakrishnan AN, Cagan A, Cai T, et al. 2015; Common genetic variants influence circulating vitamin D levels in inflammatory bowel diseases. Inflamm Bowel Dis. 21:2507–2514. DOI: 10.1097/MIB.0000000000000524. PMID: 26241000. PMCID: PMC4615315.

42. Szymczak-Tomczak A, Krela-Kaźmierczak I, Kaczmarek-Ryś M, et al. 2019; Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases. Adv Clin Exp Med. 28:955–960. DOI: 10.17219/acem/97376. PMID: 30929318.

43. Ananthakrishnan AN, Cagan A, Gainer VS, et al. 2013; Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis. 19:1921–1927. DOI: 10.1097/MIB.0b013e3182902ad9. PMID: 23751398. PMCID: PMC3720838.

44. Kabbani TA, Koutroubakis IE, Schoen RE, et al. 2016; Association of vitamin D level with clinical status in inflammatory bowel disease: a 5-year longitudinal study. Am J Gastroenterol. 111:712–719. DOI: 10.1038/ajg.2016.53. PMID: 26952579.

45. Ananthakrishnan AN, Cheng SC, Cai T, et al. 2014; Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 12:821–827. DOI: 10.1016/j.cgh.2013.10.011. PMID: 24161349. PMCID: PMC3995841.

46. El-Matary W, Sikora S, Spady D. 2011; Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci. 56:825–829. DOI: 10.1007/s10620-010-1380-5. PMID: 20725784.

47. Hassan V, Hassan S, Seyed-Javad P, et al. 2013; Association between serum 25 (OH) vitamin D concentrations and inflammatory bowel diseases (IBDs) activity. Med J Malaysia. 68:34–38.

48. 2020. Aug. 3. Vitamins and minerals: vitamin D. [Internet]. National Health Service;London (UK): Available from: https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d. cited 2020 Oct 30.

49. 2016. Jul. 21. SACN vitamin D and health report. [Internet]. The Scientific Advisory Committee on Nutrition;London (UK): Available from: https://www.gov.uk/government/publications/sacn-vitamin-d-and-health-report. cited 2020 Dec 21.

50. 2014. Nov. 26. Vitamin D: supplement use in specific population groups. [Internet]. National Institute for Health and Care Excellence;London (UK): Available from: https://www.nice.org.uk/guidance/ph56. updated 2017 Aug 30; cited 2020 Dec 21.

51. Gomolln F, Dignass A, Annese V, et al. 2017; 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 11:3–25. DOI: 10.1093/ecco-jcc/jjw168. PMID: 27660341.

52. Magro F, Gionchetti P, Eliakim R, et al. 2017; Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 11:649–670. DOI: 10.1093/ecco-jcc/jjx008. PMID: 28158501.

53. Turner D, Ruemmele FM, Orlanski-Meyer E, et al. 2018; Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline from European Crohn's and colitis organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 67:257–291. DOI: 10.1097/MPG.0000000000002035. PMID: 30044357.

54. Bischoff SC, Escher J, H?buterne X, et al. 2020;  ESPEN practical guideline: clinical nutrition in inflammatory bowel diseas. Clin Nutr. 39:632–653. DOI: 10.1016/j.clnu.2019.11.002. PMID: 32029281.

55. Pappa HM, Mitchell PD, Jiang H, et al. 2014; Maintenance of optimal vitamin D status in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing two regimens. J Clin Endocrinol Metab. 99:3408–3417. DOI: 10.1210/jc.2013-4218. PMID: 24926949. PMCID: PMC4154083.

56. Pappa HM, Mitchell PD, Jiang H, et al. 2012; Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens. J Clin Endocrinol Metab. 97:2134–2142. DOI: 10.1210/jc.2011-3182. PMID: 22456619. PMCID: PMC3387426.

57. Li J, Chen N, Wang D, Zhang J, Gong X. 2018; Efficacy of vitamin D in treatment of inflammatory bowel disease: a meta-analysis. Medicine (Baltimore). 97:e12662. DOI: 10.1097/MD.0000000000012662. PMID: 30431562. PMCID: PMC6257592.

58. Jgensen SP, Agnholt J, Glerup H, et al. 2010; Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind place-bo-controlled study. Aliment Pharmacol Ther. 32:377–383. DOI: 10.1111/j.1365-2036.2010.04355.x. PMID: 20491740.

59. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. 2011; Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 96:1911–1930. DOI: 10.1210/jc.2011-0385. PMID: 21646368.

60. Hlavaty T, Krajcovicova A, Payer J. 2015; Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much? J Crohns Colitis. 9:198–209. DOI: 10.1093/ecco-jcc/jju004. PMID: 26046136.

61. Yang L, Weaver V, Smith JP, Bingaman S, Hartman TJ, Cantorna MT. 2013; Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol. 4:e33. DOI: 10.1038/ctg.2013.1. PMID: 23594800. PMCID: PMC3636524.

62. Jun JC, Yoon H, Choi YJ, et al. 2019; The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease. Intest Res. 17:210–217. DOI: 10.5217/ir.2018.00081. PMID: 30477283. PMCID: PMC6505089.

63. Zator ZA, Cantu SM, Konijeti GG, et al. 2014; Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr. 38:385–391. DOI: 10.1177/0148607113504002. PMID: 24088707.

64. Garg M, Rosella O, Rosella G, Wu Y, Lubel JS, Gibson PR. 2018; Evaluation of a 12-week targeted vitamin D supplementation regimen in patients with active inflammatory bowel disease. Clin Nutr. 37:1375–1382. DOI: 10.1016/j.clnu.2017.06.011. PMID: 28651829.

65. Miheller P, Muzes G, Hritz I, et al. 2009; Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis. 15:1656–1662. DOI: 10.1002/ibd.20947. PMID: 19408329.

66. Joseph AJ, George B, Pulimood AB, Seshadri MS, Chacko A. 2009; 25 (OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity. Indian J Med Res. 130:133–137.

67. Garg M, Rosella O, Lubel JS, Gibson PR. 2013; Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm Bowel Dis. 19:2634–2643. DOI: 10.1097/01.MIB.0000436957.77533.b2. PMID: 24105392.

68. Alrefai D, Jones J, El-Matary W, et al. 2017; The association of vitamin D status with disease activity in a cohort of Crohn's disease patients in Canada. Nutrients. 9:1112. DOI: 10.3390/nu9101112. PMID: 29023388. PMCID: PMC5691728.